{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:00:42Z","timestamp":1790370042720,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R434-2023-342"],"award-info":[{"award-number":["R434-2023-342"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["6214271"],"award-info":[{"award-number":["6214271"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.eplepsyres.2026.107910","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:46:43Z","timestamp":1788565603000},"page":"107910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hyperphosphorylated tau pathology in patients with epilepsy and dementia \u2013 Neuropathological insights from a historical autopsy cohort"],"prefix":"10.1016","volume":"228","author":[{"given":"Silke Emilie","family":"Laustsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette Krogh","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Dyremose","family":"Cornwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wirenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-1492","authenticated-orcid":false,"given":"Christoph Patrick","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","article-title":"Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium","volume":"18","author":"Alafuzoff","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.eplepsyres.2026.107910_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fnagi.2019.00308","article-title":"Tau phosphorylation in a mouse model of temporal lobe epilepsy","volume":"11","author":"Alves","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.eplepsyres.2026.107910_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/epi4.12744","article-title":"Assessment of tau phosphorylation and \u03b2-amyloid pathology in human drug-resistant epilepsy","volume":"8","author":"Aroor","year":"2023","journal-title":"Epilepsia Open."},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107910_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.seizure.2011.10.009","article-title":"Physical injuries in patients with epilepsy and their associated risk factors","volume":"21","author":"Asadi-Pooya","year":"2012","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107910_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnen\/nlab001","article-title":"The Second NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy","volume":"80","author":"Bieniek","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.eplepsyres.2026.107910_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/epi.17186","article-title":"Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways","volume":"63","author":"Canet","year":"2022","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2026.107910_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/practneurol-2019-002341","article-title":"Localisation in focal epilepsy: a practical guide","volume":"21","author":"Chowdhury","year":"2021","journal-title":"Pract. Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2026.107910_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.eplepsyres.2026.107910_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-051222-120750","article-title":"Neurodegenerative disease tauopathies","volume":"19","author":"Creekmore","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.eplepsyres.2026.107910_bib14","article-title":"In-vivo evidence for increased tau deposition in temporal lobe epilepsy","volume":"2026","author":"Cruces","year":"2025","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2026.107910_bib16","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1111\/epi.18142","article-title":"Amyloid deposition in adults with drug-resistant temporal lobe epilepsy","volume":"65","author":"Fonseca","year":"2024","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107910_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/brain\/awz381","article-title":"Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy","volume":"143","author":"Gourmaud","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2026.107910_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.seizure.2017.02.017","article-title":"Epilepsy and cognition - a bidirectional relationship?","volume":"49","author":"Helmstaedter","year":"2017","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.eplepsyres.2026.107910_bib19","article-title":"Investigating the impact of epilepsy on cognitive function: a narrative review","volume":"15","author":"Hoxhaj","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107910_bib20","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210303","article-title":"Progression of amyloid accumulation in late adulthood among people with childhood-onset epilepsy","volume":"104","author":"Joutsa","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107910_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.eplepsyres.2026.107910_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209920","article-title":"Association of seizure foci and location of tau and amyloid deposition and brain atrophy in patients with Alzheimer disease and seizures","volume":"103","author":"Lam","year":"2024","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib23","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1212\/WNL.0000000000200736","article-title":"Poststroke seizures and the risk of dementia among young stroke survivors","volume":"99","author":"Lekoubou","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2026.107910_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1241339","article-title":"Alzheimer's disease and epilepsy: shared neuropathology guides current and future treatment strategies","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107910_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.eplepsyres.2026.107910_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2015.11.007","article-title":"Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy","volume":"1630","author":"Puvenna","year":"2016","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107910_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13317","article-title":"The prevalence of chronic traumatic encephalopathy in a historical epilepsy post-mortem collection","volume":"35","author":"Ryniejska","year":"2025","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2026.107910_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041092","article-title":"Tau-induced pathology in epilepsy and dementia: notions from patients and animal models","volume":"19","author":"S\u00e1nchez","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.eplepsyres.2026.107910_bib30","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/epi.17086","article-title":"Low prevalence of amyloid and tau pathology in drug-resistant temporal lobe epilepsy","volume":"62","author":"Silva","year":"2021","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2026.107910_bib31","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1111\/epi.16375","article-title":"Tau deposition in young adults with drug-resistant focal epilepsy","volume":"60","author":"Smith","year":"2019","journal-title":"Epilepsia"},{"issue":"Pt 9","key":"10.1016\/j.eplepsyres.2026.107910_bib32","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/aww187","article-title":"Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections","volume":"139","author":"Tai","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.eplepsyres.2026.107910_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamaneurol.2023.0339","article-title":"Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors","volume":"80","author":"Tai","year":"2023","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2026.107910_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer's disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat. Aging"},{"issue":"10172","key":"10.1016\/j.eplepsyres.2026.107910_bib35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"Pt 10","key":"10.1016\/j.eplepsyres.2026.107910_bib36","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/brain\/awr209","article-title":"Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study","volume":"134","author":"Thom","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2026.107910_bib37","unstructured":"WHO. Epilepsy: a public health imperative. Geneva; 2019."},{"issue":"2","key":"10.1016\/j.eplepsyres.2026.107910_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14020514","article-title":"Hyperphosphorylated tau and cognition in epilepsy","volume":"14","author":"Witt","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107910_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: new perspectives and challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.eplepsyres.2026.107910_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5723","article-title":"Bidirectional influences between seizures and dementia: a systematic review and meta-analysis","volume":"37","author":"Zhao","year":"2022","journal-title":"Int. J. Geriatr. Psychiatry"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126001804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126001804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:12:13Z","timestamp":1790367133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121126001804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0920121126001804"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107910","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperphosphorylated tau pathology in patients with epilepsy and dementia \u2013 Neuropathological insights from a historical autopsy cohort","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107910"}}